Page last updated: 2024-11-03

opc 12759 and Lacrimal Duct Obstruction

opc 12759 has been researched along with Lacrimal Duct Obstruction in 2 studies

rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase

Lacrimal Duct Obstruction: Interference with the secretion of tears by the lacrimal glands. Obstruction of the LACRIMAL SAC or NASOLACRIMAL DUCT causing acute or chronic inflammation of the lacrimal sac (DACRYOCYSTITIS). It is caused also in infants by failure of the nasolacrimal duct to open into the inferior meatus and occurs about the third week of life. In adults occlusion may occur spontaneously or after injury or nasal disease. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p250)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Tanaka, H1
Nakayama, T1
Tsukamoto, M1
Watanabe, A1
Nakamura, T1
Yokoi, N1
Sotozono, C1
Kinoshita, S1
Mimura, M1
Ueki, M1
Oku, H1
Sato, B1
Ikeda, T1

Other Studies

2 other studies available for opc 12759 and Lacrimal Duct Obstruction

ArticleYear
Rebamipide promotes lacrimal duct epithelial cell survival via protecting barrier function.
    Scientific reports, 2020, 02-03, Volume: 10, Issue:1

    Topics: Alanine; Animals; Anti-Ulcer Agents; Cell Survival; Cells, Cultured; Disease Models, Animal; Electri

2020
Effect of rebamipide ophthalmic suspension on the success of lacrimal stent intubation.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2016, Volume: 254, Issue:2

    Topics: Aged; Aged, 80 and over; Alanine; Anti-Ulcer Agents; Female; Humans; Intubation; Lacrimal Duct Obstr

2016